Blocknomi
TLDR MiNK Therapeutics stock moves after Phase 2 pneumonia trial update. agenT-797 shows early gains in oxygenation and infection control. Data presented at 2026 Military Health System Research Symposium event.…
Related articles
-
Moderna (MRNA) Stock Tumbles 6% Premarket Despite Improved Q2 Revenue Amid $782M Loss
Blocknomi Published 31.07.2026 12:13
-
Coldcard users face urgent seed migration warning
Crypto.News Published 02.08.2026 17:07
-
XRP Whales Holding 10M to 100M Tokens Add 1.23B XRP in 2026 Despite 43% Price Crash
The Crypto Basic Published 07.08.2026 13:50
-
Cameron Winklevoss Pushes 2 Cryptos as AI Trade Rout Sinks Kospi 11%
BeInCrypto Published 28.07.2026 16:51
-
Crypto PAC pours $1M into Michigan Democratic primary race
Cointelegraph Published 22.07.2026 20:38
-
Ethereum Approaches Key Breakout Level as Hayes Boosts Holdings
Blocknomi Published 26.07.2026 14:23
-
HashKey Cloud, BitGo Launch Non-Custodial Staking for Institutions
BlockchainReporter Published 23.07.2026 15:00
-
XRP, Bitcoin Whales Are Accumulating—Is the Bear Market Nearly Over?
Decrypt Published 06.08.2026 18:13